Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe COVID-19

Lung inflammation is a hallmark of Coronavirus disease 2019 (COVID-19) in patients who are severely ill, and the pathophysiology of disease is thought to be immune mediated. Mast cells (MCs) are polyfunctional immune cells present in the airways, where they respond to certain viruses and allergens a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Janessa Y.J., Anderson, Danielle E., Rathore, Abhay P.S., O’Neill, Aled, Mantri, Chinmay Kumar, Saron, Wilfried A.A., Lee, Cheryl Q.E., Cui, Chu Wern, Kang, Adrian E.Z., Foo, Randy, Kalimuddin, Shirin, Low, Jenny G., Ho, Lena, Tambyah, Paul, Burke, Thomas W., Woods, Christopher W., Chan, Kuan Rong, Karhausen, Jörn, St. John, Ashley L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541193/
https://www.ncbi.nlm.nih.gov/pubmed/37561585
http://dx.doi.org/10.1172/JCI149834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541193/
https://www.ncbi.nlm.nih.gov/pubmed/37561585
http://dx.doi.org/10.1172/JCI149834

Ejemplares similares